Atomoxetine in the Treatment of Adults with Subthreshold and/or Late Onset Attention‐Deficit Hyperactivity Disorder‐Not Otherwise Specified (ADHD‐NOS): A Prospective Open‐Label 6‐Week Study

The objective of this study was to evaluate the efficacy and tolerability of atomoxetine hydrochloride (ATX) in the treatment of adults with atypical manifestations of attention‐deficit hyperactivity disorder (ADHD) (not otherwise specified [NOS]). We hypothesized that treatment with ATX will be saf...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:CNS Neurosci Ther
Asıl Yazarlar: Surman, Craig, Hammerness, Paul, Petty, Carter, Doyle, Robert, Chu, Nicole, Gebhard, Nitzah, Williams, Courtney, Biederman, Joseph
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Publishing Ltd 2010
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493840/
https://ncbi.nlm.nih.gov/pubmed/20070786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2009.00124.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller